Collagen type Iα1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis

Hepatology

Volumn 33, Issue 3, 2001, Pages 554-560

  Parés, Albert ^a   Guañabens, Nuria ^a   Alvarez, Luisa ^a   De Osaba, M Jesús Martínez ^a   Oriola, Josep ^a   Pons, Francesca ^a   Caballería, Llorenç ^a   Monegal, Ana ^a   Salvador, Georgina ^a   Jo, Judith ^a   Peris, Pilar ^a   Rivera, Francisca ^a   Ballesta, Antonio M ^a   Rodés, Joan ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL RECEPTOR; COLLAGEN; VITAMIN D; VITAMIN D RECEPTOR;

ARTICLE; BILIARY CIRRHOSIS; BONE DENSITY; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HOSPITALIZATION; HUMAN; METABOLISM; MIDDLE AGED; ABSORPTIOMETRY; ADULT; ALLELE; BONE MASS; CHOLESTASIS; COLLAGEN METABOLISM; DISEASE SEVERITY; DNA POLYMORPHISM; GENETIC MARKER; LIVER DISEASE; LUMBAR SPINE; MAJOR CLINICAL STUDY; OSTEOPOROSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VITAMIN METABOLISM;

BONE DENSITY; COLLAGEN; FEMALE; GENOTYPE; HUMANS; LIVER CIRRHOSIS, BILIARY; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; SEVERITY OF ILLNESS INDEX;

EID: 17744381373     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.22758     Document Type: Article

References (44)

1. Bone disease and calcium absorption in primary, biliary cirrhosis
2. Intestinal absorption of 25-hydroxyvitamin D and osteomalacia in primary biliary, cirrhosis
3. Las manifestaciones osteoarticulares en la cirrosis biliar primaria
4. Vitamin D prophylaxis and osteomalacia in chronic cholestatic liver disease
5. 25-Hydroxyvitamin D3 treatment of bone disease in primary biliary cirrhosis
6. Osteoporosis in primary biliary cirrhosis: Effects of 25-hydroxyvitamin D3 treatment
7. Bone disease in primary biliary cirrhosis: Increased bone resorption and turnover in the absence of osteoporosis or osteomalacia
8. Bone disease in primary, biliary cirrhosis: Histologic features and response to 25-hydroxyvitamin D
9. Bone loss and reduced osteoblast function in primary biliary cirrhosis
10. Low bone turnover state in primary, biliary cirrhosis
11. A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: Hepatic improvement but greater bone loss
12. Metabolic bone disease in primary biliary cirrhosis
13. Factors influencing the development of metabolic bone disease in primary biliary cirrhosis
14. Bone disease in primary biliary cirrhosis: Does ursodeoxycholic acid make a difference?
15. Non-invasive assessment of bone density in primary biliary cirrhosis
16. Does hepatic osteodystrophy differ from peri- and postmenopausal osteoporosis: A histomorphometric study
17. Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis
18. Bone mass in women with primary biliary cirrhosis: The relation with histological stage and use of glucocorticoids
19. Genetic determinants of bone mass in adults: A twin study
20. Reduced bone mass in daughters of women with osteoporosis
21. Prediction of bone density from vitamin D receptor alleles
22. The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women
23. A large-scale population-based study of the association of vitamin D receptor gene polmorphisms with bone mineral density
24. Vitamin D-receptor gene polymorphisms and bone density in prepuberal American girls of Mexican descent
25. Vitamin D receptor polymorphisms, bone mineral density, and bone metabolism in postmenopausal Mexican-America women
26. The Bsml vitamin D receptor restriction fragment length polymorphism (BB) predicts low bone density in premenopausal black and white women
27. Reduced bone density and osteoporosis associated with a polymorphic Spl binding site in the collagen type Iα1 gene
28. Relation of alleles of the collagen type Iα1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women
29. A simple salting out procedure for extracting DNA from human nucleated cells
30. Contribution of transacting factor alleles to normal physiological variability: Vitamin D receptor gene polymorphisms and circulating osteocalcin
31. Collagen type Iα1 gene Sp1 polymorphism in premenopausal women with primary osteoporosis: Improved detection of Sp1 binding site polymorphism in the collagen type 1 gene
32. Assessment of fracture risk, its application to screening for postmenopausal osteoporosis
33. Staging of chronic non-suppurative destructive cholangitis (syndrome of primary biliary cirrhosis)
34. An Spl binding site polymorphism in the COL1AI gene predicts osteoporotic fractures in both men and women
35. Association of polymorphism at the type 1 collagen (COL1AI) locus with reduced bone mineral density, increased fracture risk, and increased collagen turnover
36. Are vitamin D receptor polyrnorphisms associated with bone mineral density? A meta-analysis
37. Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: The OFELY study
38. Lack of correlation between start codon polymorphism of the vitamin D receptor gene and bone mineral density in premenopausal French women: The OFELY study
39. Vitamin D receptor alleles and rates of bone loss: Influence of years since menopause and calcium intake
40. Do dietary calcium and age explain the controversy sourrounding the relationship between bone mineral density and vitamin D receptor gene polymorphisms?
41. Determinants of premenopausal bone mineral density: The interplay of genetic and lifestyle factors
42. Vitamin D receptor (VDR) polymorphisms and bone mineral density (BMD) in primary biliary cirrhosis
43. Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis
44. Collagen type Iα1 Sp1 polymorphism, bone mass, and bone turnover in healthy French premenopausal women: The OFELY study